SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is trending following news of a strategic manufacturing partnership aimed at significantly reducing production costs and expanding capacity, which has driven substantial intraday stock volatility. The community is actively discussing the stock's low float and high trading volume, fueling speculation about a potential short squeeze and anticipating further upward movement as it tests key resistance levels. This partnership is seen as a crucial step for scaling their fingerprint drug screening technology ahead of anticipated future market expansion.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending due to recent discussions surrounding its integration as a fuel-discount token within the EzFill app, generating buzz about its expanding utility. The community is sharply divided, with many anticipating significant future appreciation from multi-year lows and viewing it as "digital silver," while others express frustration over its recent price action and struggle to overcome key resistance levels.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is currently a focal point for year-end tax loss selling, leading to sharp price movements and a polarized community discussion. Many foresee further declines for the meme coin, while a resilient group of long-term holders views the current dip as a strategic accumulation opportunity for future crypto cycles, with eyes on a potential rally in 2026.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending significantly following the FDA approval of NEREUS, marking the first new pharmacologic treatment for motion-induced vomiting in over four decades. The community is actively discussing the drug's potential beyond motion sickness, particularly its vast opportunity in addressing GLP-1 induced nausea, which many see as a transformative revenue driver for the company. With analysts raising price targets and whispers of potential buyout interest, investors anticipate continued upside as the market fully prices in this key regulatory win and the company's robust pipeline.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESH Acquisition Corp (ESHA) is trending within a volatile low-float SPAC sector, fueled by discussions surrounding its extremely tight share float and high insider ownership. The community is actively debating its potential for rapid price movement and a short squeeze, drawing comparisons to other recently surging SPACs as new utility via a planned reward token is also highlighted.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics (CORT) is trending with significant volatility after receiving an FDA Complete Response Letter for its relacorilant drug, triggering a sharp decline in shares. The community is fiercely divided, with many calling the sell-off an overreaction given the company's existing profitable drug and deep pipeline, while others foresee further downside following analyst downgrades and a need for more clinical evidence. This binary regulatory event has intensified speculation, as investors weigh potential recovery against lingering uncertainty.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending following the FDA's acceptance and priority review of AXS-05 for Alzheimer's disease agitation, alongside positive feedback supporting an upcoming NDA for AXS-12 in narcolepsy. The market is reacting strongly to this dual pipeline advancement, with community members expressing high optimism and noting significant short-covering as a key driver of the momentum.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending after a competitor's drug for Cushing's syndrome received a regulatory setback from the FDA, which the community views as a significant advantage for Xeris's approved treatment, Recorlev. This development is seen as clearing the path for Recorlev to gain market share, fueling discussions among investors about the company's long-term growth potential and undervaluation, supported by positive analyst outlooks.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is highly active following the CME Group's recent, repeated increases in margin requirements for silver futures, sparking intense debate among traders who see it as a desperate measure to control a surging market. This volatility is further fueled by conflicting narratives around impending Chinese silver export restrictions and the growing disconnect between paper and physical prices. The community is sharply divided between those predicting a massive short squeeze driven by industrial demand and global supply shifts, and those anticipating a significant pullback.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as its community intensely debates future prospects amid persistent price challenges. Significant anticipation surrounds potential regulatory clarity from the "Clarity Act" and major developments like integrations with large retailers and payment networks. Despite widespread frustration over price action, many remain bullish, highlighting AMP's core utility in secure digital payments and its existing merchant adoption as crucial for eventual upside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gold Gearing Up for Another Solid Run? ETFs to Ride the Trend

Gold's rally shows no signs of fading. With rate cuts looming, dollar weakening and bullish forecasts in sight, here are the ETFs that investors can use to ride the trend.

Gold ETFs in the Spotlight as 2025 Draws to a Close

Gold ETFs like GLD draw attention as gold's record-breaking 2025 rally fuels strong demand for ETFs heading into 2026.

<ul class="summary-bullets"><li>At the time of writing, silver futures maturing in March 2026 delivery traded 0.1% lower at $58.64.</li><li>While silver may continue to outperform, its price action remains volatile, and overbought conditions pose a short-term risk for bullish positions, said veteran commodities expert Ole Hansen.</li><li>Gold remained steady, but DXY fell below its 50-DMA for the first time since Oct. 17.</li></ul>&nbsp;Spot silver prices climbed to record highs yet again on Wednesday, a run that has seen the metal scale fresh peaks in three of the last four sessions.The XAG/USD pair rose to an all-time high of $58.95 an ounce earlier in the session before paring some of the gains. It is currently trading at just over $58.<figure class="image"><img style="aspect-ratio:1315/862;" src="https://news.stocktwits-cdn.com/spot_silver_and_gold_png_fd52230589.webp" alt="spot silver and gold.png" width="1315" height="862"><figcaption>Spot silver and gold prices at 06:25 a.m. ET on Dec. 2, 2025 | Source: TradingView</figcaption></figure><h2 class="st-heading-2">Silver’s Surge To New Records</h2>On Friday, spot silver climbed past $55 an ounce for the first time, buoyed by a weak dollar as traders bet on a potential interest rate cut on December 10. The rally continued on Monday with silver climbing above $58 per ounce. While there have been two separate pullbacks over the past month, spot prices continue to remain well above the 50-day moving average (50-DMA).At the time of writing, silver futures maturing in March 2026 delivery traded 0.1% lower at $58.64.<h2 class="st-heading-2">Pullback On The Cards?</h2>While silver may continue to outperform, its price action remains volatile, and overbought conditions pose a short-term risk for bullish positions, veteran commodities expert and Head of Commodity Strategy for Saxo Bank, Ole Hansen, wrote in a post on X on Wednesday.<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/Ole_S_Hansen/status/1996127661463068983"><img src="https://news.stocktwits-cdn.com/Ole_Hansen_png_851796fbbc.webp" alt="Ole Hansen.png"></a>In a report for Saxo Bank, Hansen stated that, as London vault inventories are depleted to meet strong silver demand from the U.S. and India, lease rates have jumped, tightening conditions and adding pressure on traders.<h2 class="st-heading-2">Gold Remains Steady</h2>Spot gold price (XAU/USD) was down marginally at $4,200.3 per ounce on Wednesday morning. The pair has benefited from a weaker dollar and rising expectations of a rate cut this month. Recent comments from top Fed officials, along with weaker post-shutdown economic data, have reinforced market expectations for a rate cut next week.Data from the CME FedWatch tool showed an 89.2% probability of a 25-basis-point rate cut at the December 10 meeting. A week back, the figure stood slightly lower at 83.4%.<figure class="image"><a class="st-link-external" href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html" target="_blank" rel="noopener noreferrer nofollow"><img style="aspect-ratio:1290/849;" src="https://news.stocktwits-cdn.com/CME_group_png_1d4126f5b8.webp" alt="CME group.png" width="1290" height="849"></a><figcaption>Rate cut probability as of Dec. 2, 2025 | Source: CME</figcaption></figure>Meanwhile, the U.S. Dollar Index (DXY) fell for a fourth straight session. It was down 0.3% at 99.03, falling below its 50-day moving average (DMA) for the first time since October 17.<figure class="image"><img style="aspect-ratio:1315/870;" src="https://news.stocktwits-cdn.com/DXY_50_day_png_168e4ba885.webp" alt="DXY - 50-day.png" width="1315" height="870"><figcaption>DXY's 50-DMA as of Dec. 2, 2025 | Source: TradingView</figcaption></figure>&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/apple-eyes-record-i-phone-shipments-this-year-powered-by-china-rebound-report/cLIXnImREKU">Apple Eyes Record iPhone Shipments This Year, Powered By China Rebound: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising chart and reflection of business buildings: stock photo courtesy of Yuichiro Chino via Getty Images

Silver Extends Blistering Rally With Yet Another Record High

On Friday, spot silver climbed past $55 an ounce for the first time, buoyed by a weak dollar as traders bet on a potential interest rate cut on December 10. The rally continued on Monday with silver climbing above $58 per ounce.

Equity

The XAG/USD pair rose to an all-time high of $58.95 an ounce on Wednesday before paring some of the gains.

<ul><li>Speculation about a potential Fed rate cut has driven up sentiment for precious metals such as gold and silver, with spot silver hitting all-time highs earlier today.</li><li>Goldman Sachs survey shows 36% of institutional clients polled expect gold to top $5,000 per ounce by the end of 2026.</li><li>U.S. gold futures maturing in February gained over 1% to $4,244 per ounce.</li></ul>&nbsp;Spot gold (XAU/USD) climbed 1.2% on Friday to hit its highest level in two weeks. The precious metal is heading for its fourth straight monthly advance and has risen in nine of the past ten months.At the time of writing, gold traded at around $4,211 per ounce and was on track for its biggest weekly gain since the week ending Oct. 10, 2025.U.S. gold futures maturing in February gained over 1% to $4,244 per ounce.On Friday, trading was affected after a technical outage at CME Group, the world’s largest derivatives exchange, led to a halt in trading across all markets. The problem was caused by a cooling issue at a CyrusOne data centre in the Chicago area.<h2 class="st-heading-2">Fed Rate Cut Hopes</h2>Speculation about a potential Fed rate cut on December 10 has driven up sentiment for precious metals such as gold and silver.&nbsp;Earlier today, spot silver (XAG/USD) hit a<a href="https://stocktwits.com/news-articles/markets/equity/spot-silver-trades-near-all-time-highs-as-rate-cut-expectations-rise/cL5a2ZrRELX">&nbsp;fresh high</a> of $55.86 per ounce, at the time of writing, surpassing the previous record of about $54.50 set on October 17.According to data from the CME FedWatch tool, there is an 86.9% probability of a 25-basis-point rate cut at the December 10 meeting. A week back, the figure stood at 71%.Historically, periods of economic or political uncertainty have driven investors toward safe-haven assets such as gold and silver. Expectations of easier monetary policy also tend to boost precious metals by lowering borrowing costs and weakening the dollar.<h2 class="st-heading-2">Investors Remain Bullish</h2>According to a Goldman Sachs survey, as reported by CNBC on Friday, many investors believe the rally is far from over. In a poll of more than 900 institutional clients, 36% expect gold to top $5,000 per ounce by the end of 2026, while another 33% see it landing between $4,500 and $5,000.Overall, more than 70% of respondents anticipate higher prices next year, with only a small minority expecting a pullback to the $3,500 to $4,000 range.Prices have already jumped by more than 60% year-to-date, breaking above the $4,000 mark for the first time on October 8.Brokerages remain bullish, too. Earlier this month, UBS lifted its mid-2026 upside target for gold to $4,900 per ounce from $4,700, saying the forces behind this year’s rally remain intact heading into next year. The firm expects continued Fed rate cuts, lower real yields, and persistent geopolitical risks to keep demand strong.Its outlook aligns with Goldman Sachs, which also projects gold reaching $4,900 by the end of 2026.<h2 class="st-heading-2">ETF Watch</h2>The SPDR Gold Shares ETF (GLD) gained 1% to $387.2&nbsp;on Friday, with retail sentiment on Stocktwits turning “neutral” from “bearish” a day earlier.Sentiment toward the iShares Gold Trust (IAU) remained in the “neutral” territory for the past 24 hours.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

Gold nuggets on display on April 29, 2011 in Jamestown, California. 

Spot Gold Hits 2-Week Highs On Fed Rate Hopes – On Track For Fourth Straight Monthly Gain

Spot gold price has surged over 60% so far this year, gaining in nine of the last 10 months.

Gold ETFs That Investors Can Consider as the Metal Extends Its Rally

Gold's rally shows no signs of slowing, with ETFs like GLD and IAU offering prime exposure as the dollar weakens.

<ul class="summary-bullets"><li>On Friday, Federal Reserve President John Williams reportedly indicated that a third rate cut could still be on the table this year.</li><li>The Dollar index held above 100 on Monday, trading near its six-month high set on Friday.</li><li>SPDR Gold Shares ETF (GLD) was up 0.22% at $375.10 on Monday.</li></ul>&nbsp;Spot gold prices firmed up on Monday after declining for the past two sessions, with the XAU/USD pair up 0.45% at $4,084.24 per ounce.Spot gold has gained around 55% so far this year. U.S. gold futures for December delivery traded marginally lower at $4,078.10 per ounce.Gold prices rose amid rising expectations of a rate cut next month, offsetting the drag from a stronger U.S. dollar. The DXY held above 100 on Monday, trading near its six-month high set on Friday.Last week, John Williams, President and CEO of the Federal Reserve Bank of New York, reportedly indicated that a third rate cut could still be on the table this year. He noted that weakening labor market conditions now pose a greater economic risk than rising inflation, suggesting the Fed may need to reduce its key interest rate.According to data from the CME FedWatch tool, there is a 75.7% probability of a 25-basis-point rate cut at the December 10 meeting. A week back, the figure stood at 42.4%.&nbsp;Last week, the Bureau of Labor Statistics (BLS) <a href="https://stocktwits.com/news-articles/markets/equity/bls-september-jobs-report/cLPA1qDREa7">released</a> the delayed September jobs report, showing that the U.S. economy added more jobs than expected. However, the unemployment rate in September climbed to a four-year high of 4.4%, the highest since October 2021.<h2 class="st-heading-2">Brokerages Remain Bullish</h2>Last week, UBS <a href="https://stocktwits.com/news-articles/markets/equity/ubs-hikes-gold-price-forecast-again-expects-4-900-peak-by-mid-2026-report/cLPAilzRE9C">raised</a> its mid-2026 upside target for gold to $4,900 per ounce from $4,700, with the firm arguing that the fundamentals driving this year’s surge remain firmly in place heading into 2026. UBS said that the key macro drivers, including further Federal Reserve rate cuts, lower real yields, and geopolitical tension, should continue to support demand.&nbsp;UBS’ view echoes recent bullish commentary from Goldman Sachs, which also sees gold hitting $4,900 by the end of 2026.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2><a href="https://stocktwits.com/symbol/GLD">SPDR Gold Shares ETF</a> (GLD) was up 0.22% at $375.10 on Monday. Retail Sentiment on Stocktwits for GLD has remained in the ‘bearish’ territory over the past 24 hours.Retail sentiment on <a href="https://stocktwits.com/symbol/IAU">iShares Gold Trust</a> (IAU) turned 'bearish' from 'neutral' a day earlier.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-dgnx-stock-rising-premarket-today/cL5b7RnREQ5">Why Is DGNX Stock Rising Premarket Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A fine gold bar with the number 999.99 on it.

Spot Gold On Track To Snap 2-Day Loss On Rate Cut Hopes

Spot gold rose despite a strong dollar after dovish U.S. Fed comments on Friday.

<ul class="summary-bullets"><li>Gold has been on a phenomenal run this year, rising over 55%.</li><li>UBS said that macro drivers, including Federal Reserve rate cuts, lower real yields, and geopolitical tension, should continue to support demand.</li><li>Earlier this week, Goldman Sachs said that it expects gold to reach $4,900 by the end of 2026.</li></ul>&nbsp;&nbsp;Gold's relentless 55% rally this year seems far from over, according to UBS, which has raised its mid-2026 upside target for the metal to $4,900 per ounce.UBS believes that the macro forces that powered it to record highs should keep the safe-haven demand strong into 2026.Although gold has eased about 7% from last month’s record high of $4,381.6 per ounce, brokerages remain optimistic, continuing to lift their upside price forecasts.<figure class="image"><a class="st-link-external" href="https://in.tradingview.com/chart/teA7VKVN/?symbol=OANDA%3AXAUUSD" target="_blank" rel="noopener noreferrer nofollow"><img style="aspect-ratio:1306/862;" src="https://news.stocktwits-cdn.com/XAUUSD_png_e03bb6310d.webp" alt="XAUUSD.png" width="1306" height="862"></a><figcaption>XAUUSD Gold Spot Prices in October and November 2025 | Source: TradingView</figcaption></figure><h2 class="st-heading-2">UBS Raises Mid-Year 2026 Prices Forecast</h2>On Thursday, UBS raised its upside price target to $4,900 per ounce from $4,700, with the bank arguing that the fundamentals driving this year’s surge remain firmly in place heading into 2026, according to a report by investing.com.The investment bank continues to rate the metal as ‘attractive’, maintains long exposure in its global asset allocation, and says gold “remains an effective portfolio hedge even at current levels.”<h2 class="st-heading-2">What’s Driving The Target Hike?</h2>UBS analysts, led by strategist Wayne Gordon, said the recent consolidation has not altered the outlook and now expect prices to reach $4,500 per ounce by mid-2026, up from a previous forecast of $4,200 per ounce. The bank has maintained its downside case at $3,700 per ounce, the report read.UBS said that the key macro drivers, including further Federal Reserve rate cuts, lower real yields, and geopolitical tension, should continue to support demand. The analysts also highlight growing political noise ahead of the U.S. midterm elections, which could spur additional safe-haven buying.They expect prices to consolidate near $4,300 following political events in late 2026, but see scope to reach the new $4,900 upside case if global political and financial risks intensify.UBS’s view echoes recent bullish commentary from Goldman Sachs, which also sees gold hitting $4,900 by the end of 2026 with further upside if investors continue diversifying their portfolios.<h2 class="st-heading-2">How Have The ETFs Performed?</h2>Since the start of the year, SPDR Gold Shares ETF (GLD) has gained 53.5%, iShares Gold Trust (IAU) and VanEck Merk Gold Trust (OUNZ) have both climbed 53.7%, while&nbsp;abrdn&nbsp;Physical Gold Shares ETF (SGOL) and Goldman Sachs Physical Gold ETF Trust (AAAU) have risen 53.8%.<figure class="image"><a class="st-link-external" href="https://www.datawrapper.de/_/CgYnc/" target="_blank" rel="noopener noreferrer nofollow"><img style="aspect-ratio:1240/630;" src="https://news.stocktwits-cdn.com/Cg_Ync_gold_etfs_gains_in_2025_png_455c3757e5.webp" alt="CgYnc-gold-etfs-gains-in-2025-.png" width="1240" height="630"></a><figcaption>Gold ETFs Gains in 2025</figcaption></figure>&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/dow-futures-rise-nvidia-earnings-beat/cLPAWVDRE9A">Dow Futures Rise As Investors Cheer Nvidia’s Earnings Beat: NVDA, AMD, GOOGL, WMT Among Stocks To Watch</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

UBS Hikes Gold Price Forecast Again, Expects $4,900 Peak By Mid-2026: Report 

UBS lifted its upside target to $4,900 from $4,700, saying the factors behind this year’s rally should continue into 2026, according to a report by investing.com.

ETFs to Consider as Gold Jumps to 2-Week High

A weaker dollar, rate-cut bets and persistent uncertainty are fueling gold's rally, lifting demand for ETFs like GLD and GDX.

Gold Price Dips: Is This a Good Time to Invest in Gold ETFs? 

Gold's record-breaking run cools with a sharp pullback. Could this dip open a golden entry point for investors in ETFs like GLD and IAU? 

What's Next for Gold ETFs: A Pullback or Buying Opportunity?

Gold surges past $4,200, fueled by ETF inflows, Fed rate cut bets and safe-haven demand but a short-term pullback may be near.

SGOL
abrdn ETF - abrdn Physical Gold Shares ETF

Feed

News

Sentiment

Fundamentals

Info

Latest SGOL News

SGOLabrdn ETF - abrdn Physical Gold Shares ETF